Money Concepts Capital’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Sell
15,801
-603
-4% -$116K 0.17% 134
2025
Q4
$3.02M Buy
16,404
+334
+2% +$58.6K 0.17% 129
2025
Q3
$2.47M Buy
16,070
+97
+0.6% +$14.7K 0.15% 137
2025
Q2
$2.23M Sell
15,973
-290
-2% -$40.6K 0.15% 142
2025
Q1
$2.39M Sell
16,263
-110
-0.7% -$15.9K 0.18% 132
2024
Q4
$2.15M Sell
16,373
-430
-3% -$60.2K 0.16% 141
2024
Q3
$2.62M Sell
16,803
-536
-3% -$86.5K 0.2% 120
2024
Q2
$2.7M Sell
17,339
-686
-4% -$103K 0.23% 106
2024
Q1
$2.44M Buy
18,025
+84
+0.5% +$11.1K 0.23% 121
2023
Q4
$2.42M Buy
17,941
+360
+2% +$46.8K 0.22% 116
2023
Q3
$2.38M Buy
17,581
+588
+3% +$80.3K 0.25% 116
2023
Q2
$2.43M Sell
16,993
-150
-0.9% -$22.1K 0.25% 118
2023
Q1
$2.38M Sell
17,143
-2,473
-13% -$333K 0.13% 137
2022
Q4
$2.66M Buy
19,616
+1,173
+6% +$147K 0.12% 157
2022
Q3
$2.02M Buy
18,443
+830
+5% +$105K 0.12% 161
2022
Q2
$2.32M Sell
17,613
-1,564
-8% -$205K 0.21% 115
2022
Q1
$2.54M Buy
19,177
+1,699
+10% +$204K 0.14% 166
2021
Q4
$2.04M Buy
+17,478
New +$2.06M 0.17% 136
2021
Q1
$1.83M Buy
18,411
+16,385
+809% +$1.65M 0.15% 150
2020
Q4
$203K Buy
+2,026
New +$215K 0.02% 413

Other funds holding AZN

Money Concepts Capital's AZN Position: Q1 2026 in Review

Money Concepts Capital reduced its AstraZeneca (AZN) stake by 3.7% in Q1 2026, selling an estimated $116K and leaving 15,801 shares worth $3.06M. The position accounts for 0.17% of the portfolio, ranked #134.

Money Concepts Capital first reported a position in AZN in Q4 2020 and has held it in 20 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Money Concepts Capital held 15,801 shares of AstraZeneca worth $3.06M as of Q1 2026.
  • Money Concepts Capital sold 603 AstraZeneca shares in Q1 2026, an estimated $116K.
  • AstraZeneca made up 0.17% of Money Concepts Capital's portfolio in Q1 2026, its #134 holding.
  • Money Concepts Capital first reported a position in AstraZeneca in Q4 2020 and has held it in 20 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Money Concepts Capital's 13F filing for Q1 2026, filed 30 Apr 2026.